ITP-话题@MedSci - 梅斯（MedSci）

#ITP#

17篇内容 | 1505人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1418435, encodeId=3013141843562, content=<a href='/topic/show?id=c8f210115bc' target=_blank style='color:#2F92EE;'>#ITP#</a>, objectTitle=AJH：单剂量与低剂量利妥昔单抗治疗皮质类固醇耐药或复发性 ITP：一项多中心、随机、对照研究, objectType=article, longId=295312, objectId=76172953129d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=76172953129d, replyNumber=0, likeNumber=0, createdTime=2022-02-10, rootId=0, userName=whmdzju, userId=e2523357226, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=76172953129d, moduleTitle=AJH：单剂量与低剂量利妥昔单抗治疗皮质类固醇耐药或复发性 ITP：一项多中心、随机、对照研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=76172953129d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1418434, encodeId=00a8141843442, content=<a href='/topic/show?id=c8f210115bc' target=_blank style='color:#2F92EE;'>#ITP#</a>, objectTitle=Blood：血小板生成素受体激动剂在ITP老年患者中的实际应用情况, objectType=article, longId=216350, objectId=6bdb21635063, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6bdb21635063, replyNumber=0, likeNumber=99, createdTime=2021-08-28, rootId=0, userName=whmdzju, userId=e2523357226, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6bdb21635063, moduleTitle=Blood：血小板生成素受体激动剂在ITP老年患者中的实际应用情况, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=6bdb21635063)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1418433, encodeId=4a0b141843371, content=<a href='/topic/show?id=c8f210115bc' target=_blank style='color:#2F92EE;'>#ITP#</a>, objectTitle=Blood：约一半的ITP患者可能存在隐匿性脑微出血！, objectType=article, longId=199172, objectId=8d151991e27a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d151991e27a, replyNumber=0, likeNumber=76, createdTime=2020-08-12, rootId=0, userName=whmdzju, userId=e2523357226, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d151991e27a, moduleTitle=Blood：约一半的ITP患者可能存在隐匿性脑微出血！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=8d151991e27a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1418432, encodeId=d8b0141843247, content=<a href='/topic/show?id=c8f210115bc' target=_blank style='color:#2F92EE;'>#ITP#</a>, objectTitle=Blood：可抑制血小板吞噬作用的抗体，或可治疗ITP, objectType=article, longId=194263, objectId=77f519426327, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=77f519426327, replyNumber=0, likeNumber=80, createdTime=2020-05-18, rootId=0, userName=whmdzju, userId=e2523357226, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=77f519426327, moduleTitle=Blood：可抑制血小板吞噬作用的抗体，或可治疗ITP, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=77f519426327)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1418431, encodeId=3101141843181, content=<a href='/topic/show?id=c8f210115bc' target=_blank style='color:#2F92EE;'>#ITP#</a>, objectTitle=Blood：GPIbα或可作为抗GPIbα抗体诱导型ITP的生物标志物, objectType=article, longId=189806, objectId=2e57189806a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e57189806a0, replyNumber=0, likeNumber=0, createdTime=2020-03-13, rootId=0, userName=whmdzju, userId=e2523357226, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e57189806a0, moduleTitle=Blood：GPIbα或可作为抗GPIbα抗体诱导型ITP的生物标志物, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2e57189806a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1418430, encodeId=58e2141843094, content=<a href='/topic/show?id=c8f210115bc' target=_blank style='color:#2F92EE;'>#ITP#</a>, objectTitle=Blood：抑制Itpkb可预防和治疗GVHD, objectType=article, longId=181711, objectId=dedb181e1112, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dedb181e1112, replyNumber=0, likeNumber=64, createdTime=2019-10-23, rootId=0, userName=whmdzju, userId=e2523357226, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dedb181e1112, moduleTitle=Blood：抑制Itpkb可预防和治疗GVHD, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=dedb181e1112)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1418429, encodeId=2bc91418429f0, content=<a href='/topic/show?id=c8f210115bc' target=_blank style='color:#2F92EE;'>#ITP#</a>, objectTitle=Blood：艾曲波帕治疗继发于LPDs的ITP, objectType=article, longId=180492, objectId=553818049234, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=553818049234, replyNumber=0, likeNumber=83, createdTime=2019-10-05, rootId=0, userName=whmdzju, userId=e2523357226, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=553818049234, moduleTitle=Blood：艾曲波帕治疗继发于LPDs的ITP, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=553818049234)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1418428, encodeId=0b0d14184287d, content=<a href='/topic/show?id=c8f210115bc' target=_blank style='color:#2F92EE;'>#ITP#</a>, objectTitle=Chi-Med在中国启动HMPL-523治疗免疫性血小板减少症（ITP）的I期临床试验, objectType=article, longId=178212, objectId=d4f41e82121f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d4f41e82121f, replyNumber=0, likeNumber=61, createdTime=2019-08-28, rootId=0, userName=whmdzju, userId=e2523357226, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d4f41e82121f, moduleTitle=Chi-Med在中国启动HMPL-523治疗免疫性血小板减少症（ITP）的I期临床试验, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d4f41e82121f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1418427, encodeId=92d4141842e53, content=<a href='/topic/show?id=c8f210115bc' target=_blank style='color:#2F92EE;'>#ITP#</a>, objectTitle=Blood：低剂量西达本胺可恢复ITP患者的免疫耐受, objectType=article, longId=157497, objectId=626f15e4976a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=626f15e4976a, replyNumber=0, likeNumber=70, createdTime=2019-01-08, rootId=0, userName=whmdzju, userId=e2523357226, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=626f15e4976a, moduleTitle=Blood：低剂量西达本胺可恢复ITP患者的免疫耐受, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=626f15e4976a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1418426, encodeId=3281141842670, content=<a href='/topic/show?id=c8f210115bc' target=_blank style='color:#2F92EE;'>#ITP#</a>, objectTitle=Blood：ITP患儿确诊时予以IVIg预治疗可提高早期缓解率，但不影响慢性ITP发生率, objectType=article, longId=142209, objectId=89f81422092e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89f81422092e, replyNumber=0, likeNumber=0, createdTime=2018-07-04, rootId=0, userName=whmdzju, userId=e2523357226, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89f81422092e, moduleTitle=Blood：ITP患儿确诊时予以IVIg预治疗可提高早期缓解率，但不影响慢性ITP发生率, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=89f81422092e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1418425, encodeId=724c141842524, content=<a href='/topic/show?id=c8f210115bc' target=_blank style='color:#2F92EE;'>#ITP#</a>, objectTitle=Blood：脾切除仅能缓解特发性免疫性血小板减少性紫癜（ITP）的症状，并不能根治。, objectType=article, longId=125569, objectId=e81912556915, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e81912556915, replyNumber=0, likeNumber=59, createdTime=2018-01-06, rootId=0, userName=whmdzju, userId=e2523357226, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e81912556915, moduleTitle=Blood：脾切除仅能缓解特发性免疫性血小板减少性紫癜（ITP）的症状，并不能根治。, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e81912556915)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1418424, encodeId=dfb11418424db, content=<a href='/topic/show?id=c8f210115bc' target=_blank style='color:#2F92EE;'>#ITP#</a>, objectTitle=Blood：Eltrombopag（艾曲波帕）用于ITP成年患者的长期安全性和有效性, objectType=article, longId=116645, objectId=eb9611664500, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb9611664500, replyNumber=0, likeNumber=114, createdTime=2017-10-20, rootId=0, userName=whmdzju, userId=e2523357226, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb9611664500, moduleTitle=Blood：Eltrombopag（艾曲波帕）用于ITP成年患者的长期安全性和有效性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=eb9611664500)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1418423, encodeId=b3561418423dc, content=<a href='/topic/show?id=c8f210115bc' target=_blank style='color:#2F92EE;'>#ITP#</a>, objectTitle=【视频】沈志祥教授：原发免疫性血小板减少症（ITP)诊疗中国专家共识解读, objectType=article, longId=81500, objectId=fe1b81500a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe1b81500a3, replyNumber=0, likeNumber=58, createdTime=2016-11-02, rootId=0, userName=whmdzju, userId=e2523357226, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe1b81500a3, moduleTitle=【视频】沈志祥教授：原发免疫性血小板减少症（ITP)诊疗中国专家共识解读, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=fe1b81500a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1418422, encodeId=e0aa141842207, content=<a href='/topic/show?id=c8f210115bc' target=_blank style='color:#2F92EE;'>#ITP#</a>, objectTitle=2016版成人ITP诊治的中国专家共识解读（治疗）, objectType=article, longId=73705, objectId=6a64e370516, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a64e370516, replyNumber=0, likeNumber=81, createdTime=2016-07-27, rootId=0, userName=whmdzju, userId=e2523357226, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a64e370516, moduleTitle=2016版成人ITP诊治的中国专家共识解读（治疗）, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=6a64e370516)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1418421, encodeId=65f61418421d4, content=<a href='/topic/show?id=c8f210115bc' target=_blank style='color:#2F92EE;'>#ITP#</a>, objectTitle=Lancet：romiplostim对儿童免疫性血小板减少症（ITP）显著疗效, objectType=article, longId=67290, objectId=46af6e29096, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=46af6e29096, replyNumber=0, likeNumber=68, createdTime=2016-04-30, rootId=0, userName=whmdzju, userId=e2523357226, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=46af6e29096, moduleTitle=Lancet：romiplostim对儿童免疫性血小板减少症（ITP）显著疗效, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=46af6e29096)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1418420, encodeId=8006141842097, content=<a href='/topic/show?id=c8f210115bc' target=_blank style='color:#2F92EE;'>#ITP#</a>, objectTitle=Cancer Cell：关键蛋白PITPNC1通过高尔基体网络促进肿瘤细胞转移, objectType=article, longId=66607, objectId=6b5f6660ef5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6b5f6660ef5, replyNumber=0, likeNumber=0, createdTime=2016-04-19, rootId=0, userName=whmdzju, userId=e2523357226, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6b5f6660ef5, moduleTitle=Cancer Cell：关键蛋白PITPNC1通过高尔基体网络促进肿瘤细胞转移, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=6b5f6660ef5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1418419, encodeId=c6911418419e1, content=<a href='/topic/show?id=c8f210115bc' target=_blank style='color:#2F92EE;'>#ITP#</a>, objectTitle=FDA扩大了艾曲波帕片在ITP中的使用年龄, objectType=article, longId=55869, objectId=04d05586965, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=04d05586965, replyNumber=0, likeNumber=65, createdTime=2015-09-09, rootId=0, userName=whmdzju, userId=e2523357226, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=04d05586965, moduleTitle=FDA扩大了艾曲波帕片在ITP中的使用年龄, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=04d05586965)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ITP

2020-05-29

whmdzju (审核中...)

前往app查看评论内容

#ITP#

AJH：单剂量与低剂量利妥昔单抗治疗皮质类固醇耐药或复发性 ITP：一项多中心、随机、对照研究

2022-02-10

whmdzju (审核中...)

前往app查看评论内容

#ITP#

Blood：血小板生成素受体激动剂在ITP老年患者中的实际应用情况

2021-08-28

whmdzju (审核中...)

前往app查看评论内容

#ITP#

Blood：约一半的ITP患者可能存在隐匿性脑微出血！

2020-08-12

whmdzju (审核中...)

前往app查看评论内容

#ITP#

Blood：可抑制血小板吞噬作用的抗体，或可治疗ITP

2020-05-18

whmdzju (审核中...)

前往app查看评论内容

#ITP#

Blood：GPIbα或可作为抗GPIbα抗体诱导型ITP的生物标志物

2020-03-13

whmdzju (审核中...)

前往app查看评论内容

#ITP#

Blood：抑制Itpkb可预防和治疗GVHD

2019-10-23

whmdzju (审核中...)

前往app查看评论内容

#ITP#

Blood：艾曲波帕治疗继发于LPDs的ITP

2019-10-05

whmdzju (审核中...)

前往app查看评论内容

#ITP#

Chi-Med在中国启动HMPL-523治疗免疫性血小板减少症（ITP）的I期临床试验

2019-08-28

whmdzju (审核中...)

前往app查看评论内容

#ITP#

Blood：低剂量西达本胺可恢复ITP患者的免疫耐受

2019-01-08

whmdzju (审核中...)

前往app查看评论内容

#ITP#

Blood：ITP患儿确诊时予以IVIg预治疗可提高早期缓解率，但不影响慢性ITP发生率

2018-07-04

whmdzju (审核中...)

前往app查看评论内容

#ITP#

Blood：脾切除仅能缓解特发性免疫性血小板减少性紫癜（ITP）的症状，并不能根治。

2018-01-06

whmdzju (审核中...)

前往app查看评论内容

#ITP#

Blood：Eltrombopag（艾曲波帕）用于ITP成年患者的长期安全性和有效性

2017-10-20

whmdzju (审核中...)

前往app查看评论内容

#ITP#

【视频】沈志祥教授：原发免疫性血小板减少症（ITP)诊疗中国专家共识解读

2016-11-02

whmdzju (审核中...)

前往app查看评论内容

#ITP#

2016版成人ITP诊治的中国专家共识解读（治疗）

2016-07-27

whmdzju (审核中...)

前往app查看评论内容

#ITP#

Lancet：romiplostim对儿童免疫性血小板减少症（ITP）显著疗效

2016-04-30

whmdzju (审核中...)

前往app查看评论内容

#ITP#

Cancer Cell：关键蛋白PITPNC1通过高尔基体网络促进肿瘤细胞转移

2016-04-19

whmdzju (审核中...)

前往app查看评论内容

#ITP#

FDA扩大了艾曲波帕片在ITP中的使用年龄

2015-09-09

科室
- - 订阅+
  - 更多科室
工具
服务